Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle G Mitchell

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
JCO Precision Oncology|January 30, 2023
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals <i>EGFR</i> Mutations to Be Associated With Longer Overall SurvivalBrian De, Ahsan S Farooqi, Kyle G Mitchell, et al.
The Annals of Thoracic Surgery|December 9, 2021
Salvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell CancersNicolas Zhou, Wayne L Hofstetter, , et al.
Lung Cancer (Amsterdam, Netherlands)|January 17, 2022
Surgical approach does not influence changes in circulating immune cell populations following lung cancer resectionNathaniel Deboever, Daniel J McGrail, Younghee Lee, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 22, 2022
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancerBoris Sepesi, Nicolas Zhou, William N William, et al.
BJS Open|April 15, 2026
Development and validation of a short version of the MD Anderson Symptom Inventory for upper gastrointestinal surgery (short-MDASI-UGI-Surg) for postoperative patient-reported outcome-based careTaisuke Imamura, Koichi Tomita, Paula Marincola Smith, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2020
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancerKyle G Mitchell, Behrang Amini, Yunfei Wang, et al.
Annals of Surgical Oncology|March 18, 2026
ASO Visual Abstract: Patient-Reported Symptom Recovery After Upper Gastrointestinal Cancer Surgery: A Prospective Study Using the MDASI-UGI-SurgKoichi Tomita, Paula M Smith, Maho Takayama, et al.
Nature Communications|August 20, 2021
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancerTina Cascone, Annikka Weissferdt, Myrna C B Godoy, et al.
Annals of Surgical Oncology|February 19, 2026
Patient-Reported Symptom Recovery After Upper Gastrointestinal Cancer Surgery: A Prospective Study Using the MDASI-UGI-SurgKoichi Tomita, Paula M Smith, Maho Takayama, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 23, 2020
Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLCPierre-Olivier Gaudreau, Marcelo V Negrao, Kyle G Mitchell, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
JCO Precision Oncology|January 30, 2023
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals <i>EGFR</i> Mutations to Be Associated With Longer Overall SurvivalBrian De, Ahsan S Farooqi, Kyle G Mitchell, et al.
The Annals of Thoracic Surgery|December 9, 2021
Salvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell CancersNicolas Zhou, Wayne L Hofstetter, , et al.
Lung Cancer (Amsterdam, Netherlands)|January 17, 2022
Surgical approach does not influence changes in circulating immune cell populations following lung cancer resectionNathaniel Deboever, Daniel J McGrail, Younghee Lee, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 22, 2022
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancerBoris Sepesi, Nicolas Zhou, William N William, et al.
BJS Open|April 15, 2026
Development and validation of a short version of the MD Anderson Symptom Inventory for upper gastrointestinal surgery (short-MDASI-UGI-Surg) for postoperative patient-reported outcome-based careTaisuke Imamura, Koichi Tomita, Paula Marincola Smith, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2020
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancerKyle G Mitchell, Behrang Amini, Yunfei Wang, et al.
Annals of Surgical Oncology|March 18, 2026
ASO Visual Abstract: Patient-Reported Symptom Recovery After Upper Gastrointestinal Cancer Surgery: A Prospective Study Using the MDASI-UGI-SurgKoichi Tomita, Paula M Smith, Maho Takayama, et al.
Nature Communications|August 20, 2021
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancerTina Cascone, Annikka Weissferdt, Myrna C B Godoy, et al.
Annals of Surgical Oncology|February 19, 2026
Patient-Reported Symptom Recovery After Upper Gastrointestinal Cancer Surgery: A Prospective Study Using the MDASI-UGI-SurgKoichi Tomita, Paula M Smith, Maho Takayama, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 23, 2020
Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLCPierre-Olivier Gaudreau, Marcelo V Negrao, Kyle G Mitchell, et al.
Pageof 10